T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

750

Participants

Timeline

Start Date

March 31, 2003

Conditions
Hepatocellular Carcinoma
Interventions
DRUG

T138067 intravenous

DRUG

doxorubicin intravenous

Trial Locations (76)

10002

Zhitomir Regional Hospital, Zhitomir

19104

University of Pennsylvania, Philadelphia

21021

Vinnitsa Regional Clinical Oncological Center, Vinnitsa

33125

VA Medical Center, Miami

33136

University of Miami, Miami

33612

H. Lee Moffitt Cancer Center, Tampa

35294

University of Alabama, Birmingham

36011

Poltava Regional Clinical Oncological Center, Poltava

40002

Khon Kaen University, Khon Kaen

49102

Dnepropetrovsk State Medical Academy, Dnipro

50048

Krivorojsky City Oncology Center, Kryvyi Rih

50200

Chiangmai University, Muang Chiangmai

60153

Loyola University of Chicago, Maywood

69104

Zaporozhje State Medical Institute of Postgraduate Education, Zaporizhzhya

79031

Lvov State Medical University, Lviv

83092

Donetsk Regional Antitumor Center, Donetsk

94115

University of California at San Francisco, San Francisco

100021

Cancer Hospital of Chinese Academy of Medical Science (CAMS), Beijing

100036

Beijing Cancer Hospital of Peking University, Beijing

100853

Gereral Hospital of PLA, Beijing

115478

Blokhin Cancer Research Center, Moscow

119074

National University Hospital, Singapore

121356

Central Clinical Hospital of the President of the Russian Federation, Moscow

129128

Central Clinical Hospital of the Ministry of Transport, Moscow

143045

Arkhangelsk Redional Oncology Center, Department of Chemotherapy, Arkhangelsk

143423

Moscow Oncology Hospital #62, P/O Stepanovskoye

150054

Yaroslavl Regional Oncology Center, Yaroslavl

189646

Central Research Institute of Radiology of the Ministry of Health of Russian Federation, Saint Petersburg

193015

Medical Academy of Postgraduate Education, St. Petersburg, Saint Petersburg

195065

St. Petersburg Mechnikov State Medical Academy, Saint Petersburg

197022

St. Petersburg Oncology Center, Saint Petersburg

200032

Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai

200070

Shanghai Changzheng Hospital, Shanghai

210002

Nanjing Ba Yi Hospital of PLA, Nanjing

249020

Russian Academy of Medical Sciences, Obninsk

266003

The Affiliated Hospital of Medical College Qingdao University, Qingdao

344713

Rostov Research Oncology Institute, Rostov-on-Don

350040

Krasnodar City Oncology Center, Krasnodar

355018

Stavropol Regional Oncology Center, Stavropol

394000

Voronezh Regional Clinical Oncology Center, Voronezh

398005

Lipetsk, Lipetsk

400038

Chongqing Southwest Hospital, Chongqing

420012

Kazan State Medical University, Kazan'

420029

Kazan Republican Oncology Clinical Center, Kazan'

450054

Bashkiria Republican Oncology Center, Ufa

460021

Orenburg Regional Oncology Center, Orenburg

510060

Cancer Center, Sun Yat-Sen Unversity, Guangzhou

510515

Guangzhou Nanfang Hospital, Guangzhou

545087

Cheliabinsk Regional Oncology Center, Chelyabinsk

630047

Novosibirks Municipal Clinical Hospital #1, Novosibirsk

634028

Tomsk Regional Research Institute of Oncology, Tomsk

656049

Barnaul

660133

Krasnoyarsk Regional Oncology Center, Krasnoyarsk

664035

Irkutsk Regional Oncology Center, Irkutsk

710061

1st Affiliated Hospital of Xi An Jiao Tong University, Xi’an

5403000

Hospital das Clínicas da Faculdade de Medicina da USP, São Paulo

30190130

Hospital Vera Cruz, Belo Horizonte

30190131

Hospital Mater Dei - Departamento de Oncologia, Belo Horizonte

90020090

Irmandade Santa Casa de Misericórdia de Porto Alegre - Unidade de Apoio à Pesquisa, Porto Alegre

75390-9125

UT Southwestern Medical Center - Dallas, Dallas

Unknown

Queen Mary Hospital, Hong Kong

Taipei Veteran General Hospital, Taipei

Chang Gung Memorial Hospital, Taoyuan

Prince Wales Hosptial, Hong Kong

Omsk Regional Oncology Center, Omsk

Eastern Cape Oncology Centre, Port Elizabeth

80-211

Katedra i Klinika Onkologii i Radioterapi Akademii Medycznej, GdaDsk

10-228

Oddział Chemioterapii, Olsztyn

61-878

Klinika Katedry Onkologii AM, Poznan

00927

San Juan Medical Center, San Juan

01133

Kiev Central Military Clinical Hospital, Kiev

03022

Kiev Oncology Institute of Ukrainian Academy of Medical Science, Kiev

CB2 2QQ

Addenbrookes Hospital, Cambridge

NW3 2QG

Royal Free Hospital, London

W12 OH5

Hammersmith Hospital, London

M20 4BX

Christie Hospital, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Tularik

INDUSTRY

NCT00057382 - T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients | Biotech Hunter | Biotech Hunter